Stokes & Hubbell Capital Management’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q1
$3.48M Buy
43,114
+2,461
+6% +$201K 0.73% 42
2018
Q4
$3.75M Buy
40,653
+72
+0.2% +$6.33K 0.85% 31
2018
Q3
$3.84M Sell
40,581
-375
-0.9% -$35.6K 0.8% 36
2018
Q2
$3.79M Buy
40,956
+364
+0.9% +$35.5K 0.86% 33
2018
Q1
$3.84M Sell
40,592
-9,771
-19% -$1.07M 0.89% 32
2017
Q4
$4.87M Sell
50,363
-98
-0.2% -$9.24K 1.17% 20
2017
Q3
$4.48M Buy
50,461
+418
+0.8% +$31.8K 1.16% 20
2017
Q2
$3.63M Buy
50,043
+5,759
+13% +$387K 1.12% 26
2017
Q1
$2.89M Buy
44,284
+8,503
+24% +$535K 0.98% 29
2016
Q4
$2.24M Buy
35,781
+893
+3% +$54.5K 0.87% 33
2016
Q3
$2.2M Buy
34,888
+127
+0.4% +$8.22K 0.91% 27
2016
Q2
$2.15M Sell
34,761
-92
-0.3% -$5.61K 0.93% 28
2016
Q1
$1.99M Buy
34,853
+742
+2% +$41.4K 0.92% 29
2015
Q4
$2.02M Sell
34,111
-119
-0.3% -$6.85K 1.1% 25
2015
Q3
$1.86M Buy
+34,230
New +$2.23M 1.13% 20

Other funds holding ABBV